Nevirapine approval expands combo possibilities--and HIV suppression.
Vazquez
E
E
D004352:Drug Resistance, Microbial; D006678:HIV / Q000187:drug effects / Q000302:isolation & purification*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine